학술논문

Insights into type 1 diabetes from the autoimmune polyendocrine syndromes
Document Type
article
Source
Current Opinion in Endocrinology Diabetes and Obesity. 20(4)
Subject
Biomedical and Clinical Sciences
Immunology
Autoimmune Disease
Diabetes
Aetiology
2.1 Biological and endogenous factors
Inflammatory and immune system
Metabolic and endocrine
Animals
Diabetes Mellitus
Type 1
Humans
Immune Tolerance
Polyendocrinopathies
Autoimmune
T-Lymphocytes
Regulatory
autoimmune regulator gene
immune dysregulation
polyendocrinopathy
enteropathy
and X-linked disease
immune tolerance
polyglandular autoimmunity
Clinical Sciences
Endocrinology & Metabolism
Clinical sciences
Language
Abstract
Purpose of reviewAdvances in human genetics and investigations in animal models of autoimmune disease have allowed insight into the basic mechanisms of immunologic tolerance. These advances allow us to understand the pathogenesis of type 1 diabetes and other autoimmune diseases as never before. Here, we discuss the tolerance mechanisms of the autoimmune polyendocrine syndromes and their relevance to type 1 diabetes.Recent findingsDefects in central tolerance with alteration of self-antigen expression levels in the thymus are a potent cause of autoimmunity. Peripheral tolerance defects that alter T-cell activation and signaling also play an important role in the pathogenesis of diabetes and other associated autoimmune disorders, with multiple modest defects working in concert to produce disease. Regulation of the immune response through the action of regulatory T cells is a potent mode of tolerance induction in autoimmunity that is important in type 1 diabetes.SummaryRare syndromes of autoimmunity provide a valuable window into the breakdown of tolerance and identify multiple checkpoints that are critical for generation of autoimmunity. Understanding the application of these in type 1 diabetes will allow the development of future immunomodulatory therapies in the treatment and prevention of disease.